2D multi-view ResNet ensembles predict IDH mutation from MRI about as well as 3D ResNets (AUROC 0.91 vs 0.90), while MGMT methylation prediction stays near chance.
MGMT in TMZ-based glioma therapy: multifaceted insights and clinical trial perspectives
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
eess.IV 1years
2024 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Comparative Analysis of 2D and 3D ResNet Architectures for IDH and MGMT Mutation Detection in Glioma Patients
2D multi-view ResNet ensembles predict IDH mutation from MRI about as well as 3D ResNets (AUROC 0.91 vs 0.90), while MGMT methylation prediction stays near chance.